drugset / Trial / NCT00803816
Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
NaSingle-groupOpen-labelTreatment
Summary
Study efficacy of everolimus on course of uveitis: * obtain quiescence of inflammation after start of treatment * duration to obtain quiescence of inflammation * number of patients with quiescence of inflammation
Timeline
- Start
- 2007-11
- Primary completion
- 2010-09
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 1 mg | Oral |
| Subject | Everolimus | Small molecule | 2.5 mg | Oral |